Oliver Zeitz

Humboldt-Universität zu Berlin — Germany

Medicine · Health Sciences

30h-index7.3kcitations170works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(73), Glaucoma and retinal disorders(52), Retinal Imaging and Analysis(46), Retinal and Optic Conditions(42), Retinal Development and Disorders(13)

Publications170 total

Changes in choroidal vessel morphology associated with fluid leakage in central serous chorioretinopathy; a comparison of OCTA and ICGA
Graefe s Archive for Clinical and Experimental Ophthalmology·2025· 1 citedOpen Access
Long‐term outcome of Coats' disease: Implications for the classification of foveal vascular pathologies
Acta Ophthalmologica·2025· 1 citedOpen Access
Understanding access challenges to low vision care for age-related macular degeneration in Germany: results from an integrated synthesis based on experiences from affected individuals and care providers
Disability and Rehabilitation·2025
Insights into Cataract Surgery Outcomes in Age-Related Macular Degeneration
Ophthalmology Retina·2024· 1 citedOpen Access
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema
JAMA Ophthalmology·2024· 8 citedOpen Access
Perioperative Management of Coagulation Disorders in Ophthalmic Surgery
Klinische Monatsblätter für Augenheilkunde·2024Open Access
Exploring Non-Modifiable and Modifiable Determinants of Vision-Related Quality of Life in Central Serous Chorioretinopathy
Journal of Clinical Medicine·2024· 2 citedOpen Access
Using Deep Learning to Distinguish Highly Malignant Uveal Melanoma from Benign Choroidal Nevi
Journal of Clinical Medicine·2024· 19 citedOpen Access
Häufigster okkulärer Tumor des Erwachsenen: Diagnostik und Therapie des Aderhautmelanoms
Trillium Krebsmedizin·2024
Exploring the Impact of Saccharin on Neovascular Age-Related Macular Degeneration: A Comprehensive Study in Patients and Mice
Investigative Ophthalmology & Visual Science·2024· 2 citedOpen Access
Real-World Experience with Brolucizumab Compared to Aflibercept in Treatment-Naïve and Therapy-Refractory Patients with Diabetic Macular Edema
Journal of Clinical Medicine·2024· 12 citedOpen Access
A predictive atlas of disease onset from retinal fundus photographs
2024Open Access
Transcriptome Analysis of Choroidal Endothelium Links Androgen Receptor Role to Central Serous Chorioretinopathy
European Journal of Ophthalmology·2024· 1 citedOpen Access
Antikoagulation und Thrombozytenfunktionshemmung
Spektrum der Augenheilkunde·2023· 1 citedOpen Access
News from the OOG Meeting in April 2023 in Berlin
Klinische Monatsblätter für Augenheilkunde·2023
Systemic Blood Proteome Patterns Reflect Disease Phenotypes in Neovascular Age-Related Macular Degeneration
International Journal of Molecular Sciences·2023· 5 citedOpen Access
Erfahrungen von Menschen mit altersbedingter Makuladegeneration im täglichen Leben und mit der Gesundheitsversorgung in Deutschland
Optometry & contact lenses·2023· 1 cited
Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry
Graefe s Archive for Clinical and Experimental Ophthalmology·2023· 3 citedOpen Access
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial
Journal of VitreoRetinal Diseases·2022· 13 citedOpen Access
Systems medicine and artificial intelligence in retinal disease
Graefe s Archive for Clinical and Experimental Ophthalmology·2022· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Robert Vitti(18), Alyson J. Berliner(15), Jean‐François Korobelnik(13), David S. Boyer(12), Rupert Sandbrink(11), Paul M.L. Janssen(10), Gerd Hasenfuß(10), Ursula Schmidt‐Erfurth(9), Jeffrey S. Heier(9), Frank G. Holz(9), David M. Brown(9), Peter K. Kaiser(7), Quan Dong Nguyen(7), Christian Simader(7), Yuichiro Ogura(6), Yuhwen Soo(6), Carola Metzig(6), Brigitte Stemper(6), Gisbert Richard(6), Antonia M. Joussen(6)